The University of Florence is an Italian public research university located in Florence, Italy. It comprises 12 schools and has about 60,000 students enrolled.

During the past decade, University of Florence conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Florence" #1 sponsor was "Icahn School of Medicine at Mount Sinai" with 3 trials, followed by "University of Florence" with 3 trials sponsored, "Ronald Hoffman" with 2 trials sponsored, "FLUIDDA nv" with 1 trials sponsored and "Federico II University" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Florence" #1 collaborator was "Myeloproliferative Disorders-Research Consortium" with 6 trials as a collaborator, "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator, "Associazione Medici Diabetologi (AMD)" with 1 trials as a collaborator and "Associazione Nazionale Medici Cardiologi Ospedalieri" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "University of Florence" are "Myelofibrosis" (4 trials), "Essential Thrombocythemia" (3 trials), "Idiopathic Myelofibrosis" (3 trials), "Polycythemia Vera" (3 trials) and "High Risk Essential Thrombocythemia" (2 trials). Many other conditions were trialed in "University of Florence" in a lesser frequency.

Most popular intervention types in "University of Florence" are "Drug" (7 trials), "Device" (4 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (2 trials), "PEGASYS" (2 trials), "Active Comparator: TU2670 120mg" (1 trials), "Active Comparator: TU2670 240mg" (1 trials) and "Active Comparator: TU2670 320mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Florence" are 16 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Florence". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in University of Florence, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Florence, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".